Koyfin Home > Directory > Health Care > Adamas Pharma > Cash from Investing Activities

Adamas Pharma Cash from Investing Activities Chart (ADMS)

Adamas Pharma annual/quarterly Cash from Investing Activities from 2012 to 2020.
  • Adamas Pharma Cash from Investing Activities for the quarter ending June 06, 2020 was $-3m a 1,022.02% decrease of -31m year over year
  • Adamas Pharma Cash from Investing Activities for the last 12 months ending June 06, 2020 was $34m a -198.32% decrease of -67m year over year
  • Adamas Pharma Annual Cash from Investing Activities for 2019 was $89m a 178.03% increase of 158m from 2018
  • Adamas Pharma Annual Cash from Investing Activities for 2018 was $-69m a 136.87% decrease of -95m from 2017
  • Adamas Pharma Annual Cash from Investing Activities for 2017 was $26m a 204.47% increase of 52m from 2016
Other Cash Flow Metrics:
  • Adamas Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-24m a -5.06% increase of 1m year over year
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Cash from Investing Activities Data

06/2020$-3m
03/2020$-3m
12/2019$12m
09/2019$28m
06/2019$26m
03/2019$23m
12/2018$23m
09/2018$38m
06/2018$20m
03/2018$-151m

Annual ADMS Cash from Investing Activities Data

2019$89m
2018$-69m
2017$26m
2016$-27m
2015$8m
2014$-97m
2013$0m
2012$0m
2011$0m